Avanir Pharmaceuticals (Nasdaq: AVNR) announced that it is offering to sell $200 million of its common stock in an underwritten ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE